Quadria to invest in Concord Biotech2 min read . Updated: 18 Jan 2016, 02:27 PM IST
Private equity fund set to pump in `500 crore for a 20% stake in biotech firm; deal likely to close by month-end
Mumbai: Quadria Capital, a healthcare-focussed private equity (PE) fund, is set to invest ₹ 500 crore for a 20% stake in drug maker Concord Biotech Ltd, after valuing the company at nearly ₹ 2,500 crore, said three people familiar with the development.
Select your Category